Management of Hypertension and Diabetes in Internal Medicine
For optimal management of hypertension and diabetes, a targeted approach focusing on blood pressure control, glycemic management, and cardiovascular risk reduction is recommended, with specific medication choices based on comorbidities and risk factors.
Hypertension Management
Blood Pressure Targets
- Blood pressure should be categorized as non-elevated BP, elevated BP, and hypertension to guide treatment decisions 1
- For patients with diabetes, a blood pressure target of <130/80 mmHg is recommended for those with high cardiovascular risk or established cardiovascular disease 1
- For patients with diabetes and lower cardiovascular risk (10-year ASCVD risk <15%), a blood pressure target of <140/90 mmHg is appropriate 1
Screening and Diagnosis
- Blood pressure should be measured at every routine clinical visit 1
- Hypertension is defined as systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥80 mmHg based on an average of two or more measurements obtained on two or more occasions 1
- Home blood pressure monitoring is recommended for all patients with hypertension and diabetes after appropriate education 1
Treatment Approach for Hypertension
For patients with confirmed blood pressure 130-139/80-89 mmHg:
For patients with confirmed blood pressure ≥140/90 mmHg:
For patients with confirmed blood pressure ≥160/100 mmHg:
- Initiate lifestyle modifications and prompt initiation of two drugs or a single-pill combination 1
Medication Selection for Hypertension
First-line medications for patients with diabetes and hypertension include:
For patients with albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g):
For resistant hypertension (BP ≥140/90 mmHg despite three medications including a diuretic):
- Consider adding a mineralocorticoid receptor antagonist 1
Avoid combination of ACE inhibitors with ARBs due to increased risk of adverse effects without additional benefit 1
Monitoring
- For patients on ACE inhibitors, ARBs, or diuretics, monitor serum creatinine/eGFR and potassium levels at least annually 1
Diabetes Management
Glycemic Control
- Individualize glycemic targets based on patient factors, with general HbA1c target <7% for most patients 1
- Consider SGLT2 inhibitors for patients with diabetes, especially those with high cardiovascular risk, as they reduce heart failure hospitalization and cardiovascular mortality 1
Comprehensive Risk Management
- Assess cardiovascular risk factors systematically at least annually in all patients with diabetes 1
- Use SCORE2 for assessing 10-year risk of fatal and non-fatal CVD among individuals aged 40-69 years with elevated BP 1
- Use SCORE2-OP for assessing cardiovascular risk in patients ≥70 years 1
Lifestyle Modifications for Both Conditions
Dietary Recommendations
- Recommend a DASH-style dietary pattern or Mediterranean diet 1
- Reduce sodium intake (<2,300 mg/day) and increase potassium intake 1
- Increase consumption of fruits and vegetables (8-10 servings per day) and low-fat dairy products (2-3 servings per day) 1
- Reduce saturated fat and trans fat intake 1
- Increase dietary n-3 fatty acids, viscous fiber, and plant stanols/sterols 1
Physical Activity and Weight Management
- Encourage regular physical activity within the patient's limitations 1
- Recommend weight loss if overweight or obese 1
- Moderate alcohol intake (no more than 2 servings per day in men and no more than 1 serving per day in women) 1
Patient-Centered Care
- Conduct informed discussions about cardiovascular risk and treatment benefits tailored to patient needs 1
- Consider motivational interviewing to assist patients in controlling blood pressure and enhancing treatment adherence 1
- Encourage home blood pressure measurement and self-monitoring 1
- Consider multidisciplinary approaches in management 1
Common Pitfalls and Caveats
- Avoid excessive blood pressure reduction in patients with intracerebral hemorrhage (systolic BP ≥220 mmHg) - acute reduction >70 mmHg within 1 hour is not recommended 1
- Be cautious with intensive blood pressure control in elderly patients, those with chronic kidney disease, or frailty due to higher risk of adverse effects 1
- Monitor for orthostatic hypotension, especially in patients with diabetes who may have autonomic neuropathy 1
- Metformin (commonly used for diabetes) rarely causes hypoglycemia by itself but can do so if combined with other medications that lower blood sugar 2
- The presence of low diastolic blood pressure is not necessarily a contraindication to intensive blood pressure management in the context of otherwise standard care 1